| HOME >> BIOLOGY >> TECHNOLOGY |
Forward-Looking Statements
This press release contains forward-looking statements, including
without limitation statements related to our financial strength and
flexibility, the development of our pipeline, the future of our existing
collaborations, potential new collaborations, future pipeline and business
milestones and the impact and future use of the Deerfield facility. Words
such as "want," "expect," "can," "will" and similar expressions are
intended to identify forward-looking statements. These forward-looking
statements are based upon our current plans, assumptions, beliefs and
expectations. Forward-looking statements involve risks and uncertainties.
Our actual results and the timing of events could differ materially from
those anticipated in such forward- looking statements as a result of these
risks and uncertainties, which include, without limitation, risks related
to our ability to repay amounts drawn under the facility agreement in
shares of common stock, the potential failure of our compounds to
demonstrate safety and efficacy in clinical testing, our relationship with
our partners, our ability to enter into new collaborations, continue
existing collaborations and receive milestones and royalties under our
collaborative agreements, the timing and level of expenses associated with
the growth of proprietary programs and other collaborations, the ability to
co-develop and generate revenues under collaborations with our partners,
and the therapeutic and commercial value of our compounds. These and other
risk factors will be discussed in our Current Report on Form 8-K to be
filed in connection with the entry into the Facility Agreement and are
discussed under "Risk Factors" and elsewhere in our quarterly report on
Form 10-Q for
'/>"/>
| SOURCE Exelixis, Inc. Copyright©2008 PR Newswire. All rights reserved |